{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bridgewater",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "62350",
      "recalling_firm": "sanofi-aventis US, Inc.",
      "address_1": "Route 202-206",
      "address_2": "N/A",
      "postal_code": "08807",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-1407-2012",
      "product_description": "Eloxatin (OXALIplatin injection) 5 mg/mL Injection, 50 mg, Rx only, Mfd. for: sanofi aventis US LLC Bridgewater, NJ 08807, NDC 0024-0590-10",
      "product_quantity": "196,355 vials",
      "reason_for_recall": "CGMP Deviations:  Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.",
      "recall_initiation_date": "20120206",
      "center_classification_date": "20120705",
      "termination_date": "20131203",
      "report_date": "20120711",
      "code_info": "Lot number and expiration dates    Eloxatin¿ (OXALIplatin injection) 50mg vial AE41 02/ 2012   Eloxatin¿ (OXALIplatin injection) 50mg vial CA02B 02/ 2012   Eloxatin¿ (OXALIplatin injection) 50mg vial AE27 02/ 2012   Eloxatin¿ (OXALIplatin injection) 50mg vial BL18B 06/ 2012   Eloxatin¿ (OXALIplatin injection) 50mg vial CB13B 06/ 2012   Eloxatin¿ (OXALIplatin injection) 50mg vial CD65B 01/ 2014   Eloxatin¿ (OXALIplatin injection) 50mg vial CE39B 01/ 2014"
    }
  ]
}